31 – 40 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD : FLAME-based modelling in a Swedish population
(
- Contribution to journal › Article
- 2016
-
Mark
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
(
- Contribution to journal › Article
- 2015
-
Mark
Small airway epithelial-C/EBPβ is increased in patients with advanced COPD.
(
- Contribution to journal › Article
-
Mark
Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study
(
- Contribution to journal › Article
- 2014
-
Mark
Controlled and uncontrolled asthma display distinct alveolar tissue matrix compositions
(
- Contribution to journal › Article
-
Mark
lObservational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study
(
- Contribution to journal › Article
-
Mark
Hypo- and hypercapnia predict mortality in oxygen-dependent chronic obstructive pulmonary disease: a population-based prospective study
(
- Contribution to journal › Article
- 2013
-
Mark
Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study
(
- Contribution to journal › Article
-
Mark
Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD
(
- Contribution to journal › Article